Furiex Pharmaceuticals, Inc. - FORM 10-K - XML - IDEA: XBRL DOCUMENT - March 7, 2012

Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R18.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R20.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R21.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R19.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R17.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R22.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Furiex Pharmaceuticals, Inc.R9.htm
EX-32.2 - CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 - Furiex Pharmaceuticals, Inc.d276649dex322.htm
EX-32.1 - CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 - Furiex Pharmaceuticals, Inc.d276649dex321.htm
EX-31.2 - CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 - Furiex Pharmaceuticals, Inc.d276649dex312.htm
EX-31.1 - CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 - Furiex Pharmaceuticals, Inc.d276649dex311.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - Furiex Pharmaceuticals, Inc.d276649dex231.htm
EX-21.1 - SUBSIDIARIES OF FURIEX PHARMACEUTICALS, INC. - Furiex Pharmaceuticals, Inc.d276649dex211.htm
10-K - FORM 10-K - Furiex Pharmaceuticals, Inc.d276649d10k.htm
v2.4.0.6
Lease Obligations
 12 Months Ended
Dec. 31, 2011
Lease Obligations [Abstract]  
Lease Obligations

8.    Lease Obligations

The Company is currently obligated under operating leases or subleases for six locations relating to office space and associated building expenses. These leases with PPD and other third parties expire at various dates in 2012 and 2013, with renewal terms for two locations for up to one year. Prior to the spin-off, the Company recognized operating lease expense for leases which were acquired as part of the Magen acquisition. However, these operating leases obligations remained with PPD as of the spin-off date.

Rental expense related to operating leases has been recorded in continuing operations in the amounts of $0.09 million and $0.2 million for the year ended December 31, 2010 and 2011, respectively. Amounts recorded in discontinued operations were $0.3 million for the year ended December 31, 2009.

As of December 31, 2011, future minimum payments for lease obligations for subsequent years were as follows:

 

2012

    $ 115   

2013

      38   
  

 

 

  
   $ 153   
  

 

 

  

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by Furiex Pharmaceuticals, Inc. and has no official or unofficial affiliation with Furiex Pharmaceuticals, Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.